rtki cpd has been researched along with Hyperlipemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, Q; Li, W; Li, X; Liang, G; Lin, F; Wang, L; Wang, Y; Zhang, Y; Zheng, C; Zhong, P; Zou, C | 1 |
Chen, L; Fang, Q; Li, W; Li, X; Liang, G; Wang, J; Wang, L; Wang, Y; Zhang, Y; Zhong, P | 1 |
2 other study(ies) available for rtki cpd and Hyperlipemia
Article | Year |
---|---|
EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation.
Topics: Animals; Cell Line; CSK Tyrosine-Protein Kinase; Enzyme Inhibitors; ErbB Receptors; Hyperlipidemias; Immunoblotting; Inflammation; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Obesity; Oxidative Stress; Phosphorylation; Quinazolines; Rats; RNA Interference; src-Family Kinases; Tyrphostins | 2016 |
EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice.
Topics: Animals; Apolipoproteins E; Apoptosis; Cardiovascular Diseases; Cell Line; Diet, High-Fat; ErbB Receptors; Hyperlipidemias; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Palmitic Acid; Protein Kinase Inhibitors; Quinazolines; Rats; src-Family Kinases; Toll-Like Receptor 4; Tyrphostins | 2016 |